Veradermics (MANE) earnings per share (EPS)

Earnings per share · fiscal 2025
-$2.38

Veradermics (MANE) reported diluted earnings per share of -$2.38 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.37. Figures as of 17 Nov 2026, 23:41 UTC, from Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
-$2.38
Highest on record
-$1.37fiscal 2024
Lowest on record
-$2.38fiscal 2025
Fiscal years on record
32023–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Veradermics earnings per share (EPS), in more detail

Across the 3 fiscal years on record (2023–2025), the highest was -$1.37 in fiscal 2024 and the lowest -$2.38 in fiscal 2025.

History · 3 fiscal years

Earnings per share by fiscal year

Veradermics earnings per share (EPS), year by year

Veradermics (MANE) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025-$2.38—
2024-$1.37—
2023-$1.51—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Veradermics and comparable companies
CompanyEarnings per shareFiscal year
Teleflex TFX-$20.302025
Mirum Pharmaceuticals MIRM-$0.472025
Veradermics MANE-$2.382025
Grifols GRFS€0.592025
Cogent Biosciences COGT-$2.162025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MANE

Veradermics, figure by figure

Veradermics (MANE) overview: price, valuation and scorecardAll health care companies by market value

Veradermics earnings per share (EPS): questions and answers

What is Veradermics's diluted earnings per share?

Veradermics (MANE) reported diluted earnings per share of -$2.38 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$1.37.

What are the highest and lowest diluted earnings per share figures on record for Veradermics?

Across the 3 fiscal years on record (2023–2025), the highest was -$1.37 in fiscal 2024 and the lowest -$2.38 in fiscal 2025.

How is Veradermics's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Veradermics (MANE) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/MANE/eps

Underlying data: Yahoo Finance.